Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ouro Fino Saude Animal Participacoes SA
Income from Continuing Operations
Ouro Fino Saude Animal Participacoes SA
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
Income from Continuing Operations
R$222.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
12%
|
|
|
Hypera SA
BOVESPA:HYPE3
|
Income from Continuing Operations
R$1.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
13%
|
|
Ouro Fino Saude Animal Participacoes SA
Glance View
Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
See Also
What is Ouro Fino Saude Animal Participacoes SA's Income from Continuing Operations?
Income from Continuing Operations
222.3m
BRL
Based on the financial report for Dec 31, 2025, Ouro Fino Saude Animal Participacoes SA's Income from Continuing Operations amounts to 222.3m BRL.
What is Ouro Fino Saude Animal Participacoes SA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
12%
Over the last year, the Income from Continuing Operations growth was -73%. The average annual Income from Continuing Operations growth rates for Ouro Fino Saude Animal Participacoes SA have been 19% over the past three years , 20% over the past five years , and 12% over the past ten years .
